Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Breast 2Other 1Gynecologic 1

Conditions

Breast Neoplasms 2Brain Neoplasms 2Meningioma 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neuroimaging × CNS × Clear all
NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
CNS

Meningioma

NCT06247449 2025-12-18

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Sunnybrook Health Sciences Centre

Phase NA Recruiting
100 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06072807 2025-11-24

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Weill Medical College of Cornell University

Phase 4 Recruiting
20 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡